$PLL
Piedmont Lithium Inc. Stock $pll

$pll Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000172820522000040 Filed on November 04, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue		$0.00
YoY Change
Gross Profit		$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.975M	$7.271M	$11.64M
YoY Change	-22.86%
% of Gross Profit
Research & Development	$686.7K	$302.8K	$8.941M
YoY Change	-92.32%
% of Gross Profit
Depreciation & Amortization	$41.22K	$21.27K	$8.700K
YoY Change	373.79%	469.7%
% of Gross Profit
Operating Expenses	$9.703M	$7.595M	$20.58M
YoY Change	-52.86%	-26.85%
Operating Profit		-$9.597M
YoY Change		-7.56%
Interest Expense	$321.5K	$20.64K	-$121.4K
YoY Change	-364.84%	-134.95%
% of Operating Profit
Other Income/Expense, Net		$29.68M
YoY Change		-43030.0%
Pretax Income	-$9.382M	$20.10M	-$20.71M
YoY Change	-54.69%	-291.43%
Income Tax	-$283.0K	$3.400M	$0.00
% Of Pretax Income		16.92%
Net Earnings	-$10.90M	$16.66M	-$21.35M
YoY Change	-48.93%	-253.43%
Net Earnings / Revenue
Basic Earnings Per Share		$0.93
Diluted Earnings Per Share	-$0.60	$0.92	-$1.345M
COMMON SHARES
Basic Shares Outstanding	18.01M shares	17.96M shares	15.87M shares
Diluted Shares Outstanding		18.08M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.25M	$117.6M	$64.76M
YoY Change	53.26%
Cash & Equivalents	$99.25M	$117.6M	$64.24M
Short-Term Investments			$513.5K
Other Short-Term Assets	$2.612M	$3.362M	$2.515M
YoY Change	3.87%	36.18%
Inventory
Prepaid Expenses			$2.001M
Receivables	$0.00
Other Receivables
Total Short-Term Assets	$101.9M	$121.0M	$66.76M
YoY Change	52.58%	43.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$71.54M	$64.34M	$40.06M
YoY Change	78.6%	8523.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$95.65M	$96.83M	$58.87M
YoY Change	62.47%	65.42%
Other Assets	$18.87M	$15.73M	$4.561M
YoY Change	313.79%	7514.49%
Total Long-Term Assets	$186.1M	$176.9M	$103.5M
YoY Change	79.79%	85.0%
TOTAL ASSETS
Total Short-Term Assets	$101.9M	$121.0M	$66.76M
Total Long-Term Assets	$186.1M	$176.9M	$103.5M
Total Assets	$287.9M	$297.9M	$170.2M
YoY Change	69.12%	65.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.86M	$1.959M	$1.263M
YoY Change	918.54%	-30.84%
Accrued Expenses		$4.665M	$5.425M
YoY Change		27.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$425.2K	$458.6K	$762.2K
YoY Change	-44.22%	-64.38%
Total Short-Term Liabilities	$13.41M	$7.202M	$7.550M
YoY Change	77.63%	-9.15%
LONG-TERM LIABILITIES
Long-Term Debt	$163.4K	$244.7K	$914.1K
YoY Change	-82.12%	-77.18%
Other Long-Term Liabilities	$1.177M	$1.210M	$0.00
YoY Change
Total Long-Term Liabilities	$163.4K	$244.7K	$914.1K
YoY Change	-82.12%	-77.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.41M	$7.202M	$7.550M
Total Long-Term Liabilities	$163.4K	$244.7K	$914.1K
Total Liabilities	$17.63M	$12.47M	$8.464M
YoY Change	108.32%	38.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$105.7M	-$94.80M	-$92.70M
YoY Change	14.02%	15.33%
Common Stock	$1.807K	$1.799K	$1.589K
YoY Change	13.72%	15.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$270.3M	$285.4M	$161.8M
YoY Change
Total Liabilities & Shareholders Equity	$287.9M	$297.9M	$170.2M
YoY Change	69.12%	65.43%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$10.90M	$16.66M	-$21.35M
YoY Change	-48.93%	-253.43%
Depreciation, Depletion And Amortization	$41.22K	$21.27K	$8.700K
YoY Change	373.79%	469.7%
Cash From Operating Activities	-$4.407M	-$4.188M	-$17.67M
YoY Change	-75.06%	-54.8%
INVESTING ACTIVITIES
Capital Expenditures	-$10.25M	$14.39M	-$12.50M
YoY Change	-18.02%	59873.74%
Acquisitions
YoY Change
Other Investing Activities	-$24.25M	-$2.716M	-$47.91M
YoY Change	-49.38%
Cash From Investing Activities	-$14.01M	-$17.11M	-$60.41M
YoY Change	-76.82%	-66.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	71.04K	-151.0K	-319.1K
YoY Change	-122.26%	-141.44%
NET CHANGE
Cash From Operating Activities	-4.407M	-4.188M	-17.67M
Cash From Investing Activities	-14.01M	-17.11M	-60.41M
Cash From Financing Activities	71.04K	-151.0K	-319.1K
Net Change In Cash	-18.34M	-21.44M	-78.41M
YoY Change	-76.61%	-64.67%
FREE CASH FLOW
Cash From Operating Activities	-$4.407M	-$4.188M	-$17.67M
Capital Expenditures	-$10.25M	$14.39M	-$12.50M
Free Cash Flow	$5.840M	-$18.58M	-$5.175M
YoY Change	-212.85%	100.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001728205
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q2	pll	Chess Depository Interests Exchange Ratio ChessDepositoryInterestsExchangeRatio	0.01
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38427
	dei	Entity Registrant Name EntityRegistrantName	PIEDMONT LITHIUM INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4996461
	dei	Entity Address Address Line1 EntityAddressAddressLine1	42 E Catawba Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2
	dei	Entity Address City Or Town EntityAddressCityOrTown	Belmont
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28012
	dei	City Area Code CityAreaCode	704
	dei	Local Phone Number LocalPhoneNumber	461-8000
	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	PLL
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18010228	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117588915	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64244983	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3362103	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2514602	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	120951018	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	66759585	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	64342373	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40055354	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15728575	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4561122	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	96833438	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	58872710	usd
CY2022Q3	us-gaap	Assets Assets	297855404	usd
CY2021Q4	us-gaap	Assets Assets	170248771	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1959376	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1262744	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4664569	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5425498	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	458572	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	762189	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	119584	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	99587	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7202101	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7550018	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	244700	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	914147	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1210230	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3814015	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2022Q3	us-gaap	Liabilities Liabilities	12471046	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8464165	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17994576	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17994576	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15894395	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15894395	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1799	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1589	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	380140254	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	255131836	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-94754054	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92683000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3641	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-665819	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	285384358	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161784606	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	297855404	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	170248771	usd
CY2022Q3	pll	Exploration And Mine Development Costs ExplorationAndMineDevelopmentCosts	434177	usd
CY2021Q3	pll	Exploration And Mine Development Costs ExplorationAndMineDevelopmentCosts	5563028	usd
	pll	Exploration And Mine Development Costs ExplorationAndMineDevelopmentCosts	1484889	usd
	pll	Exploration And Mine Development Costs ExplorationAndMineDevelopmentCosts	12865364	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7160482	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4818647	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20199852	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11506078	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	7594659	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	10381675	usd
	us-gaap	Operating Expenses OperatingExpenses	21684741	usd
	us-gaap	Operating Expenses OperatingExpenses	24371442	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2002617	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-410538	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6547499	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-475164	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9597276	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10792213	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-28232240	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24846606	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	373204	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	373492	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3830	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	20640	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	59051	usd
	us-gaap	Interest Expense InterestExpense	97250	usd
	us-gaap	Interest Expense InterestExpense	191966	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-35469	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10095	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-60118	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-35627	usd
CY2022Q3	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	29367281	usd
CY2021Q3	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	0	usd
	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	29367281	usd
	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	0	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29684376	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-69146	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29583405	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-223763	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20087100	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10861359	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1351165	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25070369	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3422219	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3422219	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	16664881	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-10861359	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2071054	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25070369	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.64
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.64
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	811301	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17965858	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15863027	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17343309	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15242261	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18081486	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15863027	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17343309	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15242261	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	16664881	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-10861359	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2071054	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25070369	usd
CY2022Q3	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	811301	usd
CY2021Q3	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	105263	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	662178	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	73975	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	105263	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	662178	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	73975	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17476182	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10756096	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1408876	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24996394	usd
CY2022Q3	us-gaap	Oci Equity Method Investment Tax Parent OciEquityMethodInvestmentTaxParent	391796	usd
	us-gaap	Oci Equity Method Investment Tax Parent OciEquityMethodInvestmentTaxParent	391796	usd
CY2021Q3	us-gaap	Oci Equity Method Investment Tax Parent OciEquityMethodInvestmentTaxParent	0	usd
	us-gaap	Oci Equity Method Investment Tax Parent OciEquityMethodInvestmentTaxParent	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2071054	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25070369	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2643433	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1851805	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6547499	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-475164	usd
	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	29367281	usd
	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3422219	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Depreciation Depreciation	32475	usd
	us-gaap	Depreciation Depreciation	6485	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	72253	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	113914	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-11542	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-51969	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	959175	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2374222	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-68819	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-115551	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	270493	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	576344	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2627020	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	2547983	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22041466	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21988447	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21891950	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22352553	usd
	pll	Advances Paid On Equity Method Investment AdvancesPaidOnEquityMethodInvestment	9815418	usd
	pll	Advances Paid On Equity Method Investment AdvancesPaidOnEquityMethodInvestment	0	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	14086972	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	58940518	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45794340	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-81293071	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	122059476	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	114087891	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	93326	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	773251	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	973064	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	563466	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	121179738	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	114297676	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	53343932	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11016158	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64244983	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70936994	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117588915	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81953152	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2226692	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	97250	usd
	us-gaap	Interest Paid Net InterestPaidNet	191966	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	212393	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	241002	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161784606	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	122059476	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-85908	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	193644	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-9154632	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	274797186	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1591231	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	93326	usd
CY2022Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-342767	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9581303	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	266557673	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1350503	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q3	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	811301	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	16664881	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	285384358	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	79328671	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	114087891	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	406488	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30452	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6576038	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	187277464	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	611808	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	185699	usd
CY2021Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-31288	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-7632972	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	180410711	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	833509	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	557100	usd
CY2021Q3	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	105263	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-10861359	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	171045224	usd
	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Fiscal Year-End</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2022, we changed our fiscal year end from June 30 to December 31. The six-month period from July 1, 2021, to December 31, 2021, served as a transition period. Our fiscal year for 2022 commenced on January 1, 2022, and will end on December 31, 2022. See our Transition Report on Form 10-KT (“Transition Report”) filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2022.</span></div>
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-94800000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92700000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates and assumptions on current facts, historical experience and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></div>
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64386968	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	40099120	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44595	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43766	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	64342373	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40055354	usd
CY2022Q3	us-gaap	Depreciation Depreciation	21267	usd
CY2021Q3	us-gaap	Depreciation Depreciation	3733	usd
	us-gaap	Depreciation Depreciation	32475	usd
	us-gaap	Depreciation Depreciation	6485	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	64233609	usd
CY2022Q3	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4032068	usd
CY2022Q3	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	29367281	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2002617	usd
CY2022Q3	us-gaap	Oci Equity Method Investment Before Tax OciEquityMethodInvestmentBeforeTax	1203097	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	96833438	usd
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	16262498	usd
CY2021Q3	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	42582106	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-410538	usd
CY2021Q3	us-gaap	Oci Equity Method Investment Before Tax OciEquityMethodInvestmentBeforeTax	105263	usd
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	58539329	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	58872710	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	14086972	usd
	pll	Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates GainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	29367281	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6547499	usd
	us-gaap	Oci Equity Method Investment Before Tax OciEquityMethodInvestmentBeforeTax	1053974	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	96833438	usd
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	58940518	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-475164	usd
	us-gaap	Oci Equity Method Investment Before Tax OciEquityMethodInvestmentBeforeTax	73975	usd
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	58539329	usd
CY2022Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	700000	usd
CY2021Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1700000	usd
CY2022Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	461542	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	513511	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2900561	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2001091	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3362103	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2514602	usd
CY2022Q3	pll	Equity Method Investment Advances EquityMethodInvestmentAdvances	14125591	usd
CY2021Q4	pll	Equity Method Investment Advances EquityMethodInvestmentAdvances	4310173	usd
CY2022Q3	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	275115	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	190030	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1327869	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60919	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15728575	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4561122	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1300000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1300000	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	pll	Capital Shares Reserved For Future Issuance Amount CapitalSharesReservedForFutureIssuanceAmount	369200000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1358391	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	833509	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3714477	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1851805	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	7888	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	0	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	858651	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	0	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1350503	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	833509	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2855826	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1851805	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	-1260528	usd
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	-833509	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	-2643433	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	-1851805	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	89975	usd
CY2021Q3	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	212393	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-1350503	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-833509	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2855826	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-1851805	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	272504	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	443694	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	135957	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000	shares
CY2022Q1	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	15000	shares
CY2021Q1	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	18906	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	19458	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	474788	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	374003	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	58949	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	33004	shares
CY2022Q2	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	37500	shares
CY2021Q2	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	115288	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	719	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	394733	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	392504	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q3	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	36250	shares
CY2021Q3	pll	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod	120000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10900000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	358483	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	272504	shares
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7100000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	16664881	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16664881	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10861359	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10861359	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2071054	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2071054	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-25070369	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25070369	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17965858	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15863027	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17343309	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15242261	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	115628	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18081486	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15863027	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17343309	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15242261	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.64
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.64
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	305062	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	369249	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	475368	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	369249	shares
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20100000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1400000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25100000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.170
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.533
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q3	pll	Deferred Tax Effects Related To Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates DeferredTaxEffectsRelatedToGainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	3400000	usd
	pll	Deferred Tax Effects Related To Gain Loss On Dilution Of Equity Investments In Unconsolidated Affiliates DeferredTaxEffectsRelatedToGainLossOnDilutionOfEquityInvestmentsInUnconsolidatedAffiliates	3400000	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4000000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001728205-22-000040-index-headers.html	Edgar Link	pending
0001728205-22-000040-index.html	Edgar Link	pending
0001728205-22-000040.txt	Edgar Link	pending
0001728205-22-000040-xbrl.zip	Edgar Link	pending
ex311-q3.htm	Edgar Link	pending
ex312-q3.htm	Edgar Link	pending
ex321-q3.htm	Edgar Link	pending
ex322-q3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pll-20220930.htm	Edgar Link	pending
pll-20220930.xsd	Edgar Link	pending
pll-20220930_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
pll-20220930_cal.xml	Edgar Link	unprocessable
pll-20220930_def.xml	Edgar Link	unprocessable
pll-20220930_lab.xml	Edgar Link	unprocessable
pll-20220930_pre.xml	Edgar Link	unprocessable
pll-20220930_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLL
Piedmont Lithium Inc. Stock $pll

2022 Q4 Form 10-Q Financial Statement

#000172820522000040 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLL Piedmont Lithium Inc. Stock $pll

2022 Q4 Form 10-Q Financial Statement

#000172820522000040 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLL
Piedmont Lithium Inc. Stock $pll